MINDCURE Files Provisional Patent Application For iSTRYM, its Proprietary AI Digital Therapeutics (DTx) SaaS Platform, Designed To Enhance Effectiveness Of Psychedelic-Assisted Therapies For Practitioners And Patients
- Wednesday, March 31, 2021, 7:05
- Finance
- Add a comment
Company Now Is In Two High Growth Rate Global Markets With iSTRYM In The DTx Market, Projected To Reach $56 Billion By 2025 And The Global Psychedelic Market Projected To Reach Over $7.5 Billion By 20281 VANCOUVER, BC, March 31, 2021 /PRNewswire/ – Mind Cure Health Inc. (CSE: MCUR)…
About the Author
adminasapcorp has written 38959 stories on this site.